IGF1 and retinopathy of prematurity: The main objective of this study was to validate our screening test for ROP in patients >30 weeks of gestational age and >1,250 g birth weight, born between 2013 and 2018, based on our knowledge of the disease and the role of IGF1, and to establish groups with high and low risk of developing ROP.